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This study is designed to determine the effect of collagen membrane (CM) soaked with bone morphogenetic protein-2 (rhBMP-2)
for the treatment of peri-implant dehiscence defects.Material and Methods. Three treatment groups were allocated at each defect
in 5 dogs: (i) collagenated synthetic bone (OC) and CM soaked with rhBMP-2 (BMP group), (ii) OC and CM soaked with saline
(nonBMP group), and (iii) no further treatment (control group). Titanium pins were used to stabilize the membranes in two dogs.
Radiographic and histomorphometric analyses were performed 4 weeks later. Results. The median augmented volumes were 4.27
mm3, 6.24 mm3, and 2.75 mm3 in the BMP, nonBMP, and control groups, respectively; the corresponding median first bone-to-
implant contact (fBIC) distances were 3.25 mm, 3.08 mm, and 2.56 mm (𝑃 > 0.05). The placement of pins (with the BMP and
nonBMP groups pooled) significantly improved bone regeneration: the augmented volumes were 17.60 mm3 with pins and 3.68
mm3 without pins (𝑃 = 0.024), with corresponding fBIC distances of 2.25 mm and 3.31 mm, respectively (𝑃 < 0.001). Conclusions.
The addition of rhBMP-2 to CM failed to improve bone regeneration of peri-implant dehiscence defects compared to using an
unsoaked CM after 4 weeks. However, the stabilization of CMs using pins positively influenced the outcomes.
1. Introduction
Guided bone regeneration (GBR) using collagen membrane
(CM) is a well-documented treatmentmodality for augment-
ing localized peri-implant bone defects, with many clinical
and preclinical studies demonstrating that exposed implant
surfaces can be successfully augmented [1–5]. However, this
type of resorbable membrane appears to result in insufficient
space maintenance, which is reportedly due to the pressure
from the covering flap resulting in membrane collapse [3, 6].
Recent research has focused on techniques and materials to
overcome these drawbacks [7–9].
Recombinant human bone morphogenetic protein-2
(rhBMP-2) has well-documented osteogenic properties that
significantly improve bone regeneration [10–13]. Recent
reviews have also considered rhBMP-2 to be the most
promising bioactive molecules for bone regeneration [14–16].
Clinical considerationsmean that dental implants need to
be placed in prosthetically ideal positions, which often results
in buccal dehiscence defects. Several preclinical and clinical
studies have evaluated rhBMP-2 in combination with various
bone-substitute materials for localized bone regeneration for
this type of peri-implant defect [10, 11, 17, 18]. RhBMP-2
was combined with the bone-substitute material in all of
these studies; although this resulted in successful treatment
outcomes and superiority compared to control groups, the
outcomes were to some extent controversial and limited by
the clinical applicability of soaking bone-substitute materials
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with rhBMP-2. One option would be to use a CM as a carrier
for rhBMP-2, since this would potentially be advantageous in
being closer to the highly osteogenic periosteum containing
abundant mesenchymal cells. In addition, a rapid bone
formation on the outer side of the defect might result in
a more stable augmented area. Based on this assumption,
Chang and colleagues used a CM as a carrier for rhBMP-
2 for primary horizontal bone augmentation, demonstrating
a proof of concept [18]. However, this combination has not
previously been evaluated for the clinically more common
peri-implant defects.
Therefore, the aim of the present study was to determine
the effect of a CM soaked with rhBMP-2 for the treatment of
peri-implant dehiscence defects.
2. Material and Methods
2.1. Study Design. The present experiments were designed as
a controlled preclinical study involving five mongrel dogs.
The dogs were aged 12–15 months and a mean body weight
of 30 kg. They had no systemic disease and showed a healthy
periodontium and intact dentition.The study was performed
in accordance with the Animal Care and Use Committee,
Yonsei Medical Center, Seoul, Korea (permission no. 2011-
0188).
2.2. Experimental Materials. The following materials were
used in the study:
(1) Titanium implants with a sandblasted and acid-
etched surface (3.8 mm in diameter and 8 mm long)
(Implantium, Dentium, Seoul, Korea).
(2) A collagenated synthetic bone (OC; OSTEON Col-
lagen, Dentium) consisting of a particulate bone-
substitute material [70% hydroxyapatite (HA) and
30% 𝛽-tricalcium phosphate] and a type I collagen.
(3) A resorbable CM containing HA particles (HA colla-
gen membrane, GENOSS, Suwon, Korea).
(4) rhBMP-2 (Cowellmedi, Busan, Korea) at a concentra-
tion of 0.5 mg/ml, which was obtained by reconsti-
tuting and diluting rhBMP-2 in a buffer solution.The
HA-containing CMswere soaked in 0.2ml of rhBMP-
2 solution for 15 minutes at room temperature.
2.3. Surgical Procedures. Oral prophylaxis was applied to
all dogs prior to the surgical intervention. Details of the
surgical procedures are available elsewhere [19]. In brief,
general anesthesia as well as local infiltration anesthesia at
the surgical sites was applied. Crevicular incisions were then
made from the second premolar to the first molar, and two
vertical incisions were made on the buccal gingiva. Following
hemisectioning, the second, third, and fourth premolars and
the first molar were extracted on one side of the mandible.
The buccal bone plates were removed, resulting in an acute
defect with dimensions of 5 mm (apico-coronal width) by
5 mm (bucco-oral depth) and extending from the second
to the fourth premolar. Primary wound closure was then
performed. The sutures were removed 10 days later.
2.4. Implant Placement and Guided Bone Regeneration.
Twelve weeks later, dental implants were placed and simulta-
neous GBR was performed (Figure 1). Following flap reflec-
tion, the healed ridge was flattened and three implants were
placed with their platforms flush with the lingual bone crest.
This resulted in a peri-implant dehiscence defectwith a height
of 3 mm at the buccal aspect (Figure 2(a)). The cortical bone
plate was perforated in the vicinity of the implants, and GBR
was performed. The following three treatment modalities
were applied (Figure 2(c)):
(1) OC and a CM containing HA particles soaked with
rhBMP-2 (BMP group).
(2) OC and a CM containing HA particles soaked with
sterile saline (nonBMP group).
(3) No GBR (control group).
The control group was always located at the center
implant site to minimize the influence of the BMP molecule
on adjacent groups, while the BMP and nonBMPgroupswere
allocated to the mesial or distal implant sites randomly.
In group BMP, the OC was grafted on the peri-implant
defect and coveredwith aCMcontainingHAparticles soaked
with rhBMP-2. In group nonBMP, the OC was grafted on the
peri-implant defect and then covered with a CM containing
HA particles soaked with saline. No overaugmentation was
attempted in either of these groups. In two of the five
dogs, two titaniumpins (Friosmembrane tacks, DENTSPLY
Implants, Mannheim, Germany) were used to stabilize the
membranes in the BMP and nonBMP groups, while no
fixation pins were applied in the remaining three dogs. In
addition, the CM was perforated on top of the implant and
immobilized by a cover screw.No graftmaterial ormembrane
was used on the control group.
Periosteal releasing incisions were subsequently made
and primary wound closure was achieved using a resorbable
suture material (Monosyn 4.0 Glyconate Monofilament, B.
Braun, Tuttlingen, Germany). The sutures were removed 10
days later.The dogs were sacrificed by an overdose of sodium
pentobarbital 4 weeks after implant placement and GBR
surgery.
2.5. Radiographic Analysis. The specimens were scanned
using micro-CT (SkyScan 1072, SkyScan, Aartselaar, Bel-
gium) and the total augmented volume (TAV, mm3) was
measured, which represented the regenerated tissue sur-
rounding the implant. Mineralized tissue was considered to
be indicated in the images by grayscale values from 39 to
52 (defined as radiopaque tissue). The lower border of the
TAV was located 3 mm below the implant platform, and the
coronal border was defined by the most-coronal location of
radiopaque tissue. The buccolingual extension of the TAV
ranged from the center of the implant to the most-buccal
radiopaque tissue (at an angle of 90∘ to the implant surface).
Themesiodistal borders of the TAVwere confined by vertical
lines 7 mm from the center of the implant surface (Figure 3).
The implant itself was excluded from the TAV.
Cross-sectional images of each group are presented in
Figure 4. The total augmented materials were painted using
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Figure 1: Schematic drawings of the surgery design: (a) BMP group, (b) nonBMP group, and (c) control group. Blue circles, bone-substitute
materials; dark-red line, CM soaked with rhBMP-2; green line, CM soaked with saline; BMP group, cylinder-type bone-substitute material
covered by CM soaked with rhBMP-2; nonBMP group, cylinder-type bone-substitute material covered by CM soaked with saline; control
group, no further treatment.
(a) (b) (c)
Figure 2: Clinical photographs of the bone augmentation procedure applied to peri-implant dehiscence defects: (a) buccal and (b) occlusal
views after implant placement and (c) GBR treatment performed on dehiscence defects according to group assignment. The control group
was placed at the center implant site, and the BMP and nonBMP groups were randomly allocated to the mesial and distal implant sites.
(a) (b)
Figure 3: Schematic configuration of the TAV (mm3). (a) The lower border of the TAV was located 3 mm below the implant platform. The
coronal border was defined by the most-coronal location of radiopaque tissue.The buccolingual extension of the TAV ranged from the center
of the implant to the most-buccal radiopaque tissue (at an angle of 90∘ to the implant surface). (b) The mesiodistal borders of the TAV were
confined by vertical lines 7 mm from the center of the implant surface. The implant itself was excluded from the TAV. P, implant platform.
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(a) (b) (c) (d) (e)
Figure 4: Cross-sectional radiographic images demonstrating variations both between and within the groups: (a) BMP group with pins, (b)
nonBMP group with pins, (c) BMP group without pins, (d) nonBMP group without pins, and (e) control group. In the BMP and nonBMP
groups, the shape of the augmented region appeared to be predominantly influenced by the use of pins.
(a) (b) (c) (d)
Figure 5: Three-dimensional reconstructed color-coded images of the total augmented area: (a) BMP group with pins, (b) nonBMP group
with pins, (c) BMP group without pins, and (d) nonBMP group without pins. No remaining peri-implant defects were observed in the
specimens with pins, in contrast with the sites without pins and control sites without GBR.
OnDemand 3D software (Cybermed, Seoul, Korea) to facili-
tate identification of the bone regeneration (Figure 5).
2.6. Histologic Analysis. Block specimens were harvested that
included the implants and grafted siteswith surrounding hard
and soft tissues, and they were fixed in 10% neutral buffered
formalin for 10 days. The specimens were then trimmed
and dehydrated in ethanol before being embedded in methyl
methacrylate. Specimens were cut in the center of the implant
sites in a buccolingual plane and stained with hematoxylin-
eosin and Masson’s trichrome. The final thickness of the
sections was 20 𝜇m.
2.7. Descriptive Histology. The histology sections were exam-
ined under a light microscope (BX-50, Olympus Opti-
cal, Tokyo, Japan) to identify relevant structures such as
the implants, new bone formation, bone-substitute mate-
rial, nonmineralized tissue, and the remaining peri-implant
defect.
2.8. Histomorphometric Analysis. Histomorphometric mea-
surements were made at the buccal aspect of all implants.
An image-analysis program (Adobe Photoshop CS6, Adobe
Systems, San Jose, CA, USA) was used to assess the following
landmarks: implant platform (P), the first bone-to-implant
contact (B), and the most-coronal buccal bone (BC) (Fig-
ure 6).
2.8.1. Linear Measurements. The following linear measure-
ments were made:
(1) Distance between the implant platform (P) and the
first bone-to-implant contact (B) (fBIC, mm).
(2) Vertical distance between the most-coronal buccal
bone (BC) and the implant platform (P) (P-BC, mm).
(3) The bone-to-implant contact (BIC, %), measured
along the implant surface between the implant plat-
form (P) and extending 4 mm apically.
2.8.2. Area/Surface Measurements. A rectangular area of
interest (AOI) was defined on the buccal side of the implants
and included the following dimensions: coronal (implant
platform), apical (4 mm apically toward the implant plat-
form), and horizontal (2 mm from the implant surface).
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Figure 6: Schematic configuration for the histomorphometric
analysis. P, implant platform; BC, most-coronal buccal bone; B, first
bone-to-implant contact; red box, AOI. Scale bar = 500 𝜇m.
The ratios of the following outcomes to the AOI area were
measured:
(1) Newly formed bone (NB, %).
(2) Residual bone-substitute material (RBS, %).
(3) Nonmineralized tissue (NMT, %).
2.9. Statistical Analysis. Mean and standard deviation values
were calculated in each group. One-way analysis of variance
and the Bonferroni post hoc test were used to assess the
clinical benefit of soaking theCMwith the rhBMP-2 solution.
The independent 𝑡-test was used to identify differences
among groups related to the use of pins. The cutoff for
statistical significance was 𝑃 < 0.05.
3. Results
3.1. Clinical Findings. All of the dogs remained healthy, with
no wound dehiscence or membrane exposure being detected
throughout the experiments. All of the obtained sampleswere
included in the analyses.
3.2. Radiographic Analysis. The cross-sectional images
demonstrated variations both between and within the groups
(Figure 4). In the BMP and nonBMP groups, the shape of the
augmented region appeared to be predominantly influenced
by the use of pins. No remaining peri-implant defects were
observed in the specimens with pins, in contrast with the
sites without pins and control sites without GBR (Figure 5).
The median TAV values were 4.27 mm3, 6.24 mm3,
and 2.75 mm3 in the BMP, nonBMP, and control groups,
respectively (all 𝑃 > 0.05) (Table 1). When the groups were
divided according to the presence or absence of fixation pins,
the median TAV was significantly higher in the group with
pins (17.60 mm3) than in that without pins (3.68 mm3) (𝑃 =
0.024) (Table 2).
Table 1: Measured the total augmented volume (TAV) values. 𝑃
value for intergroup comparison = 0.376. 𝑛 = number of sites/dogs.
Group TAV (mm3)
BMP group 4.27 (3.08–18.23)
with pins (𝑛 = 2) 20.87 (19.55–22.20)
without pins (𝑛 = 3) 3.08 (1.68–3.68)
nonBMP group 6.24 (5.71–7.52)
with pins (𝑛 = 2) 12.25 (9.88–14.62)
without pins (𝑛 = 3) 5.71 (3.15–5.98)
Control group 2.75 (1.98–4.80)
Data are median (interquartile range) values.
3.3. Histologic Observations and Histomorphometric Analysis.
In the twoGBRgroups (i.e., BMP andnonBMP), bone forma-
tion was generally observed along the implant surfaces (Fig-
ure 7). However, defect resolution was not consistent, with
some specimens in both groups exhibiting complete regener-
ation and otherswith remaining peri-implant bone defects. In
control sites, the size of the peri-implant defects appeared to
be similar to that prior to augmentation. Complete resolution
of the dehiscence defects was consistently observed in the
histology specimens of the BMP and nonBMP groups using
pins, with new bone having formed at the apical border of
the bone defect and around the bone-substitute particles. In
contrast, the positioning of the bone-substitute particles was
disrupted and bone regeneration did not occur uniformly in
the group without pins.
The median fBIC distances were 3.25 mm, 3.08 mm, and
2.56 mm in the BMP, nonBMP, and control groups, respec-
tively, with corresponding median BIC values of 11.90%,
18.24%, and 21.96%.
Within theAOI, themedianNBswere 12.84%, 8.06%, and
21.75% in the BMP, nonBMP, and control groups, respectively.
The median RBS was 1.31% in the BMP group and 12.43%
in the nonBMP group. There were no significant intergroup
differences (𝑃 > 0.05). All of the data are reported in Table 3.
All of themeasured histomorphometric and radiographic
values (except for RBS in histomorphometric analyses) dif-
fered significantly with the presence or absence of pins when
10 specimens were divided according to the use of pins
(Table 2). The median NB was 37.03% with pins and 4.87%
without pins in the BMP group and 47.18% with pins and
7.90% without pins in the nonBMP group. BIC was higher
in both the BMP and nonBMP groups with pins (40.38% and
33.19%, respectively) than without pins (10.49% and 10.69%,
respectively) (Table 3).
4. Discussion
This study has revealed that (i) the addition of rhBMP-
2 to a CM does not significantly improve peri-implant
bone regeneration and (ii) fixation of the CM using pins
significantly increases bone regeneration compared to using
a CM without pins.
This study was designed to evaluate the usefulness of a
CM as a carrier for rhBMP-2 for guided bone regeneration at
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Figure 7: Histologic views presenting the results of GBR: (a) BMP group with pins, (b) nonBMP group with pins, (c) BMP group without
pins, (d) nonBMP group without pins, and (e) control group. The results for defect resolution were not consistent, as demonstrated by some
specimens in both the BMP and nonBMP groups exhibiting complete regeneration and others with remaining peri-implant bone defects.
Complete resolution of the dehiscence defects was consistently observed in the histology specimens of the BMP and nonBMP groups using
pins, while the positioning of bone-substitute particles was disrupted and bone regeneration did not occur uniformly in the group without
pins. In the control sites, the size of the peri-implant defects appeared to be similar to the situation prior to augmentation. Asterisk, newly
formed bone; arrow, residual bone-substitute material. Scale bar = 1 mm.
Table 2: Radiographic and histomorphometric outcomes, with data for the BMP and nonBMP groups pooled according to the use of pins.
With pins (𝑛 = 4) Without pins (𝑛 = 6) 𝑃
Radiographic volume TAV, mm3 17.60 (7.52–23.52) 3.68 (0.27–5.71) 0.024
Linear measurements
BIC, % 40.38 (18.24–48.15) 10.59 (2.61–26.12) 0.027
fBIC, mm 2.25 (1.95–2.38) 3.31 (3.08–0.87) <0.001
P-BC, mm 0.59 (0.00–1.27) 2.91 (2.51–3.44) 0.001
Measurements in the AOI
NB, % 42.54 (28.69–54.66) 6.56 (3.40–12.84) 0.006
RBS, % 8.03 (0.00–19.01) 6.86 (0.00–23.66) 0.908
NMT, % 53.46 (32.92–56.66) 84.94 (68.29–95.29) 0.002
Data are median (interquartile range) values.
𝑛 = number of sites/dogs. TAV (mm3) = the total augmented volume; BIC (%) = the bone-to-implant contact; fBIC (mm) = distance between the implant
platform and the first bone-to-implant contact; P-BC (mm) = vertical distance between the most-coronal buccal bone and the implant platform; NB (%) =
newly formed bone; RBS (%) = residual bone-substitute material; NMT (%) = nonmineralized tissue.
Table 3: Histomorphometric measurements.
Linear measurements Measurements in the AOI
Group BIC, % fBIC, mm P-BC, mm NB, % RBS, % NMT, %
BMP group 11.90(10.49–34.65)
3.25
(2.29–3.36)
2.64
(1.27–2.75)
12.84
(4.87–28.69)
1.31
(0.00–12.42)
82.71
(54.63–87.16)
with pins
(𝑛 = 2)
40.38
(37.52–43.25)
2.25
(2.23–2.27)
0.64
(0.32–0.95)
37.03
(32.86–41.20)
9.51
(4.75–14.26)
53.46
(52.88–54.05)
without pins
(𝑛 = 3)
10.49
(6.55–11.20)
3.36
(3.31–3.62)
2.75
(2.70–3.04)
4.87
(4.14–8.86)
1.31
(0.65–6.86)
87.16
(84.94–91.22)
nonBMP group 18.24(10.69–26.12)
3.08
(2.38–3.17)
2.51
(0.65–3.06)
8.06
(7.90–39.71)
12.43
(3.63–19.56)
68.29
(56.66–75.23)
with pins
(𝑛 = 2)
33.19
(25.72–40.67)
2.17
(2.06–2.27)
0.59
(0.56–0.62)
47.18
(43.45–50.92)
8.03
(5.83–10.23)
44.79
(38.85–50.73)
without pins
(𝑛 = 3)
10.69
(10.33–18.41)
3.17
(3.13–3.31)
3.06
(2.79–3.25)
7.90
(6.56–7.98)
19.56
(9.78–21.61)
75.2
(71.76–83.66)
Control group 21.96(8.16–5.04)
2.56
(2.55–3.74)
2.04
(1.60–3.56)
21.75
(3.19–22.91) 0.00
78.25
(77.09–96.81)
𝑃 0.873 0.664 0.679 0.550 0.313 0.152
Data are median (interquartile range) values.
𝑛 = number of sites/dogs.
None of the outcome measured differed significantly between the three groups (𝑃 > 0.05).
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peri-implant dehiscence defects. Previous experiments that
employed a similar protocol using animals and 30-mm peri-
implant defects demonstrated that this model can serve as a
valid alternative to clinical studies [20, 21].
Various preclinical models have demonstrated that
rhBMP-2 improves bone regeneration by accelerating osteo-
genesis predominantly at the early stage of wound healing
[22, 23]. In addition, the healing time is reportedly twofold
shorter in dogs than in humans [24], and so earlier obser-
vation periods were established in this present study when
evaluating the efficacy of rhBMP-2 compared to the previous
experiments. In the present study, the bone formation at 4
weeks was greater in the GBR groups (by up to 47%) than
at the untreated control sites (22%). This is in line with the
reporting greater bone formation for GBR groups compared
to the control sites, although those results were for longer
healing periods of 8 and 16 weeks [21]. However, the addition
of rhBMP-2 to a CM in the present study was not beneficial
to bone regeneration compared to a CM soaked in saline at
the early stage of healing of 4 weeks.
The other main difference between these two
studies—apart from the healing period—was in the type of
carrier material used. Various carrier materials have been
used for rhBMP-2 [25–27]. It was speculated that using a
CM as a carrier for rhBMP-2 could enhance the osteoin-
ductivity of the periosteum due to the close proximity of
the membrane and the periosteum. It was also speculated
that an rhBMP-2 carrier in such a location would result in
faster bone regeneration at the borders of the defect area,
thereby ideally leading to shell-like bone formation, which
could further compensate the disadvantages of a resorbable
nonspace-maintaining membrane. However, this outcome
was not observed in the present study, with no shell-like bone
formation observed in any of the samples. In a preliminary
study that used a GBR protocol and materials similar to
those in the present study [18], histomorphometric analyses
revealed that new bone formed closer to the membrane
in the group with an rhBMP-2-loaded membrane than in
the group with rhBMP-2 loaded on the bone-substitute
material. This was observed as the new bone formed directly
underneath the membrane in the group with rhBMP-2
loaded membrane. The differences in the observed bone
regeneration pattern between these two studies might have
been due to different healing periods (8 weeks versus 4
weeks), the placement of implants versus GBR alone, and the
use of fixation pins.
Stability of the surgical site and space maintenance are
considered to be essential for successful bone regeneration.
The stabilization of a GBR site appears to be the critical factor
governing the amount of bone formation. In a clinical study,
it was found that bone formation was superior when using
fixation pins [4]. This was subsequently supported by two in
vitro studies that evaluated the effect of wound closure on
the stability of GBR sites using variousmaterial combinations
[6, 28], which found that the bone-substitute material moved
apically upon wound closure. However, CMs were used at all
sites, and it is well known that this type of membrane is weak
mechanically and so may not be able to resist compressive
forces. This can result in collapse of the membrane and the
above-mentioned displacement of bone-substitute material.
However, the studies have demonstrated that applying addi-
tional fixation pins can reduce the membrane displacement
by 50% at the level of the implant shoulder. The clinical
recommendationwas to add fixation pins whenCMs are used
in combination with particulate graft materials [6]. Fixation
pins were used in two of the five dogs in the present study.The
failure to standardize the experimental method was due to
not being possible to fix the pins on thick, rigid cortical bone
without deformation. The results demonstrate the beneficial
bone formation at sites where pins are used. However, it could
be considered to use alternative fixation materials, such as
miniscrews which have better strength than pins in case of
performing GBR on a rigid bony plate.
Apart from the fixation pins, more-rigid barrier mem-
branes [29] or more-stable grafting materials provide fur-
ther advantages in stabilizing the augmented site [30]. This
was implemented in the present study by combining a
cylindrical type of synthetic bone-substitute material with
a type I collagen matrix and HA-coated CMs. This bone-
substitute material incorporating a collagen matrix was
considered to resist compressive forces and to support the
augmented ridge volume [31]. An in vitro study using a simi-
lar membrane coated with HA demonstrated a significantly
enhanced chemical stability and an improved mechanical
structure of the membrane [32]. Moreover, the cross-linked
chemical structure stiffened the CM and thereby reduced
the risk of collapse [33]. Such a membrane theoretically
exhibits all the characteristics necessary to support space
maintenance. However, in clinical experiments the increased
stiffness resulted in major difficulties in handling the mem-
brane and applying it properly to the defect site, which
meant that displacement of the graft material could not be
avoided.
The outcomes of this study are limited by several factors,
including the relatively small number of experimental ani-
mals, the use of pins in only two of the five dogs, the han-
dling difficulties with the membrane resulting in suboptimal
clinical outcomes, and the short observation period. Further
studies involving larger numbers of animals and appropriate
statistical analyses are required to confirm the results of this
study.
5. Conclusion
The use of rhBMP-2 soaked on a CM as a carrier material did
not result in superior bone formation compared to control
sites without rhBMP-2. However, the use of fixation pins to
stabilize the CMs did exert a positive effect on peri-implant
bone regeneration.
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